Get Your Personalized Supplement StackSupplement Stack Quiz

Mullein Flower Extract

Also known as: Common mullein, Great mullein, Velvet mullein, Mullein flower extract, Verbascum thapsus

Overview

Verbascum thapsus, commonly known as mullein, is a medicinal herb traditionally utilized for its therapeutic properties, particularly in addressing respiratory ailments such as coughs, bronchitis, asthma, and tonsillitis. This botanical extract is rich in various phytochemicals, including saponins, iridoid glycosides, phenylethanoid glycosides, and flavonoids, alongside vitamin C and essential minerals. Mullein extracts are available in different forms, such as teas, tinctures, and oils, and are applied both orally and topically. While traditional use is widespread, the scientific research on mullein is predominantly preclinical or ethnopharmacological. High-quality clinical trials, especially randomized controlled trials (RCTs), are limited, resulting in evidence quality that is generally low to moderate. Despite this, its long history of traditional use suggests a promising profile for further investigation into its potential health benefits.

Benefits

Mullein exhibits several evidence-based benefits, primarily due to its rich phytochemical composition. Its most notable effect is antimicrobial activity against various bacterial strains, including *Escherichia coli*, *Klebsiella pneumoniae*, and *Staphylococcus aureus*, largely attributed to its saponin and flavonoid content. It also shows potential antiviral and anti-inflammatory properties, which are particularly relevant for respiratory conditions. Traditionally, mullein has been used for conditions like hemorrhoids, varicose veins, and hypertension, possibly due to flavonoid-mediated vasodilation and antioxidant effects. While preclinical studies demonstrate moderate antimicrobial activity (MICs generally >500 μg/ml), robust clinical data on effect sizes and clinical significance in humans are currently lacking. The primary population benefiting from mullein is adults with respiratory conditions, though specific pediatric or geriatric data from RCTs are unavailable. Traditional use suggests short-term administration during acute episodes, but optimal duration is not clinically defined.

How it works

The therapeutic actions of mullein are primarily mediated by its diverse phytochemicals. Saponins contribute to its antimicrobial effects by disrupting bacterial cell membranes. Flavonoids, such as rutin, provide antioxidant, anti-inflammatory, and vasodilatory properties, potentially through α-adrenergic receptor antagonism, which may contribute to its traditional use in hypertension. Phenylethanoid glycosides are believed to exert anti-inflammatory and antiviral effects, possibly by modulating pro-inflammatory cytokines like IL-2 and TNF-α. While these mechanisms are supported by preclinical and in silico studies, detailed data on the absorption and bioavailability of these compounds in humans are sparse. Flavonoids generally exhibit moderate oral bioavailability, suggesting systemic effects are possible.

Side effects

Mullein is generally considered safe, with a low incidence of adverse effects reported in traditional use. No significant hepatotoxicity or serious adverse events have been documented in high-quality studies. A systematic review on herb-induced liver injury did not identify mullein as a cause, supporting its relative safety compared to some other herbs. However, due to limited clinical safety data, caution is advised. Allergic reactions are rare but possible, particularly in individuals sensitive to pollen. There are no known major drug interactions or contraindications identified in the current literature. Despite its good safety profile in traditional use, the lack of extensive clinical trials means that comprehensive safety data, especially for long-term use or in specific populations, are still limited. Individuals with known plant allergies should exercise caution.

Dosage

There is no standardized dosing for mullein established through rigorous clinical trials. Traditional preparations vary widely, with common doses for teas involving 1-2 grams of dried leaves or flowers infused in hot water. Extracts and oils are also used, often topically or for inhalation in traditional practices. The optimal dosage, timing of administration, and specific formulation for different therapeutic purposes require further clinical validation. Due to the lack of standardized clinical data, it is difficult to specify upper limits or safety thresholds. Users should adhere to traditional preparation guidelines or consult with a healthcare professional knowledgeable in herbal medicine for personalized advice, especially given the absence of robust clinical trials to define precise dosing for efficacy and safety.

FAQs

Is it safe for long-term use?

Safety data for mullein are limited. Short-term use appears safe based on traditional accounts, but the effects of long-term administration are not well-studied and remain unknown.

Can mullein be combined with conventional medications?

There are no documented major drug interactions with mullein. However, due to limited clinical data, caution is advised when combining it with conventional medications, and consultation with a healthcare provider is recommended.

How soon can benefits be expected from mullein?

Traditional use suggests symptomatic relief within a few days for acute conditions. However, there are no clinical trial data to confirm this timeframe or provide an evidence-based expectation for the onset of benefits.

Research Sources

https://www.scielo.br/j/rbfar/a/ysw95KyRfvgpNXtzWnqqTFh/ – This review by Riaz et al. (2013) summarizes the phytochemistry and pharmacology of *Verbascum thapsus*. It highlights in vitro antimicrobial activity against various bacterial strains, with minimum inhibitory concentrations generally above 500 μg/ml, indicating moderate activity. The study is a literature review with some experimental data but lacks clinical trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8281430/ – This source, likely part of the Blanco-Salas et al. (2021) work, reviews the phytochemical composition and molecular targets of *Verbascum* species. It emphasizes the anti-inflammatory and vasodilatory mechanisms, particularly through flavonoids and phenylethanoids, and includes in silico docking studies suggesting interaction with pro-inflammatory cytokines like IL-2 and TNF-α. This evidence is primarily preclinical and computational, without clinical trial data.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8301161/ – This source, also likely part of the Blanco-Salas et al. (2021) work, further explores the phytochemical composition and molecular targets of *Verbascum* species. It reinforces the understanding of anti-inflammatory and vasodilatory mechanisms mediated by flavonoids and phenylethanoids. The research presented is based on preclinical and computational studies, lacking human clinical trial data.
https://jptcp.com/index.php/jptcp/article/view/8818 – This source, likely related to the Blanco-Salas et al. (2021) research, contributes to the understanding of *Verbascum* species' phytochemicals and their biological activities. It supports the anti-inflammatory and vasodilatory effects attributed to compounds like flavonoids and phenylethanoids. The findings are derived from preclinical and computational studies, not clinical trials.
https://pdfs.semanticscholar.org/b213/da0878c9d07928820b9c03ea3a6467f29b18.pdf – This source, likely part of the Blanco-Salas et al. (2021) research, provides further insights into the phytochemical composition and molecular targets of *Verbascum* species. It supports the anti-inflammatory and vasodilatory mechanisms through flavonoids and phenylethanoids, including in silico studies on cytokine interactions. The evidence is primarily preclinical and computational, without clinical trial data.